<nav class="mainNavbar navbar navbar-expand-lg navbar-light bg-header mb-4">
  <div class="container">
    <a class="navbar-brand" href="#">
      <img src="../assets/images/logo-home.png" alt="" class="img-fluid" width="150px">
    </a>
    <!-- <button class="navbar-toggler" type="button" data-bs-toggle="collapse" data-bs-target="#navbarSupportedContent"
      aria-controls="navbarSupportedContent" aria-expanded="false" aria-label="Toggle navigation">
      <span class="navbar-toggler-icon"></span>
    </button> -->
    <div class="" id="navbarSupportedContent">
      <ul class="navbar-nav ms-auto mb-lg-0">
        <!-- <li class="nav-item">
          <a class="nav-link active text-light" aria-current="page" href="#">Home</a>
        </li> -->
        <li class="nav-item">
          <a class="nav-link text-light" href="#">
            <h2 class="mb-0">News Letter</h2>
          </a>
        </li>
      </ul>
    </div>
  </div>
</nav>

<section class="blogs-listing">

  <div class="container">
    <div class="row card-listing-row">
      <div class="col-md-8">
        <div class="blogs-card">
          <div class="title">
            <h3>
              <a href="news1.html">
                New Drug Shows Promise in Treating ‘Incurable’ Fatal Syndrome
              </a>
            </h3>
            <small class="text-muted">
              Source:
              <a href="https://leedaily.com/2023/01/16/new-drug-shows-promise-in-treating-incurable-fatal-syndrome/"
                target="_blank">
                https://leedaily.com/2023/01/16/new-drug-shows-promise-in-treating-incurable-fatal-syndrome/
              </a>
            </small>
          </div>
          <div class="date-time">
            <span>January 16, 2023</span>
            <!-- <span>Mr. Gautam</span>
                              <span>Trending</span> -->
          </div>
          <div class="description">
            1. Alagille syndrome is a rare genetic illness that affects multiple body systems, including the liver,
            and can be fatal if not treated.

          </div>
          <div class="mt-3 read-more">
            <div class="text-end">
              <a href="news1.html">Read More</a>
            </div>
          </div>
        </div>
      </div>
      <div class="col-md-4" style="height:220px;">
        <div class="tags-list sidebar-box">
          <h3 class="sidebar-title mb-3 border-bottom border-secondary p-2" style="position: sticky;">
            Tags
          </h3>

          <div style="overflow-y:scroll; height:166px;">
            <li>Genetic illness: Alagille syndrome</li>
            <li>Newly created medicine: NoRA1</li>
            <li>Cell-level signaling system: Notch pathway</li>
            <li>Biological structure: bile duct</li>
            <li>Organ: liver</li>
            <li>Species used in medical research: zebrafish</li>
            <li>Research institute: Sanford Burnham Prebys Medical Discovery Institute</li>
            <li>Molecular scientist: Chengjian Zhao</li>
            <li>Molecular biologist: Duc Dong</li>
            <li>Scientific journal: Proceedings of the National Academy of Sciences</li>
          </div>
        </div>
      </div>
    </div>
    <div class="row card-listing-row">
      <div class="col-md-8">
        <div class="blogs-card">
          <div class="title">
            <h3>
              <a href="news2.html">
                Old antipsychotic drugs may offer a new option to treat Type 2 diabetes
              </a>
            </h3>
            <small class="text-muted">
              Source:
              <a href="https://troymedia.com/health/old-antipsychotic-drugs-may-offer-a-new-option-to-treat-type-2-diabetes/"
                target="_blank">
                https://troymedia.com/health/old-antipsychotic-drugs-may-offer-a-new-option-to-treat-type-2-diabetes/
              </a>
            </small>
          </div>
          <div class="date-time">
            <span>January 16, 2023</span>
            <!-- <span>Mr. Gautam</span>
                              <span>Trending</span> -->
          </div>
          <div class="description">
            &bull; Researchers have discovered that a class of older antipsychotic drugs could be a potential
            therapeutic option for Type 2 diabetes patients who cannot take other available treatments.

          </div>
          <div class="mt-3 read-more">
            <div class="text-end">
              <a href="news2.html">Read More</a>
            </div>
          </div>
        </div>
      </div>
      <div class="col-md-4" style="height:220px;">
        <div class="tags-list sidebar-box">
          <h3 class="sidebar-title mb-3 border-bottom border-secondary p-2" style="position: sticky;">
            Tags
          </h3>

          <div style="overflow-y:scroll; height:166px;">
            <li>Person: John Ussher</li>
            <li>Drug: metformin, insulin secretagogues, pimozide, diphenylbutylpiperidines (DPBP)</li>
            <li>Disease: Type 2 diabetes</li>
            <li>Journal: Diabetes</li>
          </div>
        </div>
      </div>
    </div>
    <div class="row card-listing-row">
      <div class="col-md-8">
        <div class="blogs-card">
          <div class="title">
            <h3>
              <a href="news3.html">
                UW biotech spinout raises $5M to develop gene therapy system for muscular dystrophy
              </a>
            </h3>
            <small class="text-muted">
              Source:
              <a href="https://troymedia.com/health/old-antipsychotic-drugs-may-offer-a-new-option-to-treat-type-2-diabetes/"
                target="_blank">
                https://troymedia.com/health/old-antipsychotic-drugs-may-offer-a-new-option-to-treat-type-2-diabetes/
              </a>
            </small>
          </div>
          <div class="date-time">
            <span>January 24, 2023</span>
            <!-- <span>Mr. Gautam</span>
                              <span>Trending</span> -->
          </div>
          <div class="description">
            1. Myosana Therapeutics, a Seattle-based biotech startup, raised $5 million to develop a gene therapy for
            Duchenne muscular dystrophy (DMD).

          </div>
          <div class="mt-3 read-more">
            <div class="text-end">
              <a href="news3.html">Read More</a>
            </div>
          </div>
        </div>
      </div>
      <div class="col-md-4" style="height:220px;">
        <div class="tags-list sidebar-box">
          <h3 class="sidebar-title mb-3 border-bottom border-secondary p-2" style="position: sticky;">
            Tags
          </h3>

          <div style="overflow-y:hidden; height:166px;">
            <li>Myosana Therapeutics (Company)</li>
            <li>Duchenne muscular dystrophy (Disease)</li>
            <li>dystrophin (Protein)</li>
          </div>
        </div>
      </div>
    </div>
    <div class="row card-listing-row">
      <div class="col-md-8">
        <div class="blogs-card">
          <div class="title">
            <h3>
              <a href="news4.html">
                Development of Intravitreal Gene Therapy at the University of Houston for the Treatment of Usher
                Syndrome Type 2A using DNA Nanoparticles and Hyaluronic Acid Nanospheres
              </a>
            </h3>
            <small class="text-muted">
              Source:
              <a href="https://health.economictimes.indiatimes.com/news/diagnostics/study-reveals-expanding-gene-therapy-for-rare-disease-that-causes-blindness/97221071"
                target="_blank">
                https://health.economictimes.indiatimes.com/news/diagnostics/study-reveals-expanding-gene-therapy-for-rare-disease-that-causes-blindness/97221071
              </a>
            </small>
          </div>
          <div class="date-time">
            <span>January 22, 2023</span>
            <!-- <span>Mr. Gautam</span>
                              <span>Trending</span> -->
          </div>
          <div class="description">
            &bull; A University of Houston researcher is developing a gene therapy technique to treat Usher Syndrome
            Type 2A, a rare genetic condition caused by mutations in the USH2A gene.
          </div>
          <div class="mt-3 read-more">
            <div class="text-end">
              <a href="news4.html">Read More</a>
            </div>
          </div>
        </div>
      </div>
      <div class="col-md-4" style="height:220px;">
        <div class="tags-list sidebar-box">
          <h3 class="sidebar-title mb-3 border-bottom border-secondary p-2" style="position: sticky;">
            Tags
          </h3>

          <div style="overflow-y:scroll; height:166px;">
            <li>University of Houston (Organization)</li>
            <li>Usher Syndrome Type 2A (Medical Condition)</li>
            <li>USH2A gene (Gene)</li>
            <li>Retinitis pigmentosa (Medical Condition)</li>
            <li>Hearing loss (Medical Condition)</li>
            <li>Visual loss (Medical Condition)</li>
            <li>Blindness (Medical Condition)</li>
            <li>Usherin (Protein)</li>
          </div>
        </div>
      </div>
    </div>
  </div>
</section>

<footer class="footer">
  <div class="container">
    <div class="row">
      <div class="col-md-3 text-start">
        <div class="footer-logo">
          <img src="../assets/images/logo-home.png" alt="" width="200px">
        </div>
      </div>
      <div class="col-md-6">
        <div class="address">
          <p>BioXcel LLC.<br>
            2614 Boston Post Road Suite #33B , Guilford |<br>
            CT 06437 | USA</p>
        </div>
      </div>
      <div class="col-md-3">
        <address>
          <h3>Our family of Companies</h3>
          <ul>
            <li><a href="">BioXcel Therapeutics</a></li>
            <li><a href="">InveniAI® LLC</a></li>
            <li><a href="">E.Z. BioXcel</a></li>
          </ul>
        </address>
      </div>
    </div>
  </div>
  <div class="bottom-copy">
    <p class="mt-4">Copyright &copy; 2022, BioXcel Therapeutics, Inc. All rights reserved.</p>
  </div>
</footer>